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Abstract 
Chronic obstructive pulmonary disease (COPD) is increasing among the Swedish population. 
Today approximately one in ten in the ages 45 and 65 are affected by the disease but WHO 
predicts that COPD will become the third leading cause of death worldwide by 2030. 
Improved care could lead to less suffering for the individual and lower costs for society. 
In September 2015, the Deputy Hospital Manager at Sahlgrenska University Hospital signed 
an order to create a clinic dedicated to the treatment of COPD. The order states that the clinic 
shall exist for 3 years until an evaluation should be made determining its continued existence.  
This paper compares knowledge of the disease, smoking habits and adherence to therapy by 
comparing newly admitted and recurring patients at the COPD-centre using a questionnaire 
designed to measure these variables. Recurring patients has a better knowledge about their 
disease, a difference that is statistically significant, on the contrary, there is no statistical 
difference on adherence to medication even though a graphical difference can be seen. The 
information on smoking is effective. 34% of the newly admitted patients smoke regularly 
whereas only 15% of the recurring patients do so, a 56% reduction in active smokers. 
A visit to the COPD-centre is positive for the patients. Their knowledge about COPD 
increases, which earlier studies has shown having a positive impact on adherence to therapy, 
and the share of active smokers is reduced significantly. Nonetheless, continued research is 
needed to more specifically target exactly what a visit to the COPD-centre does that causes 
this positive change. 
 
  
5 
 
Background 
Chronic obstructive pulmonary disease[1] (COPD) is increasing among the Swedish 
population.[2] Today approximately one in ten in the ages 45 and 65 are affected by the 
disease but WHO predicts that COPD will become the third leading cause of death worldwide 
by 2030.[3] Improved care could lead to less suffering for the individual and lower costs for 
society. The actions to improve care could be a complex mixture of change in attitude, the 
given information, technical support and improved medical therapy where adherence is a vital 
part.[4] 
Improving a patient’s adherence could benefit from having a much broader approach than just 
looking at how they adhere to their medication. The impact on adherence would benefit from 
having a more holistic view, where also other factors such as gender and level of education 
gets included.[5]  
The adherence to medication may be defined as to the degree a patient takes their medical 
prescriptions and is one of the greatest challenges with drug development and therapies. 
Adherence to long term treatment is on average less than 50 %, which indicates that there is a 
lot of untapped potential in drug therapies.[4] Increasing the effectiveness of all parts in the 
care by stressing the adherence may have a far greater impact on the health of the population 
than any improvement in specific medical treatments[6]. Nonadherence is complex and may 
be due to the life style, the patient, the regimen and the device, why the motivation, the 
support and the education is essential. Besides being less effective medical treatments, recent 
publications found that non-adherence to medications for the treatment of chronic conditions 
leads to annual loss of $637 billion for pharmaceutical companies[7] and $375 billion in 
treatment cost in the US[8].  
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The understanding of how visits to a specialist clinic may change the adherence in COPD 
patients could be essential in increasing adherence elsewhere.  
Most patients get their diagnosis and first treatment of COPD at the family practice. Since 
only severe COPD, or severe symptoms caused by the disease, usually get treated at a 
specialty clinic[1], the understanding of causes to any possible increase in adherence gained 
by visits to a specialist clinic could be essential for improving treatment of the disease.  
Since the disease is increasing worldwide and since patients usually have low adherence to 
long term medications, studies aimed at finding ways to increase adherence to the treatment of 
COPD is beneficial both from an individual as from a societal perspective. 
The COPD-centre at Sahlgrenska University Hospital 
In September 2015, the Deputy Hospital Manager at Sahlgrenska University Hospital signed 
an order to create a clinic dedicated to the treatment of COPD. The order states that the clinic 
shall exist for 3 years until an evaluation should be made determining its continued 
existence.[9] The results of this paper support the Sahlgrenska Hospital Management in 
making an informed decision when determining whether or not the clinic should be made 
permanent. 
Epidemiology 
COPD is more prevalent in communities with a higher percentage of smokers since smoking 
tobacco is the leading cause of COPD. It mostly affects older adults who either are active 
smokers or have been smoking earlier in life. The patients often also have one or several other 
chronic diseases, of which asthma and different cardiovascular diseases are some of the more 
prevalent ones.[10] 
In 2010 COPD affected a bit less than 5% of the earth’s population, about 330 million 
people.[11] In 2018 between 400,000 and 700,000 persons in Sweden have COPD and the 
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number of affected is expected to increase. In Sweden COPD is the main cause of death of 
about 2700 people per year.[10, 12] 
Diagnosis 
Even though the common chest x-ray often shows signs of COPD, a confident diagnosis of 
the disease can only be made with spirometry. If a patient shows symptoms that correlates  
with classical symptom of the disease, such as shortness of breath, chronic cough, sputum 
and/or if the patient has exposure to, or have had exposure to, risk factors such as smoking, 
pollution or has genetic or habitual risk factors then the physician should order a spirometry 
for that patient.[13] 
The spirometry is done after bronchodilators have been taken by the patient and the ratio 
between FEV1/FEV is calculated. A value of < 0.7, or < 0,65 for ages > 65, determines if you 
have COPD. Thereafter the FEV1 gets compared to a predicted value, and the percentage of 
FEV1 to that value determines what stage of COPD the patient has.[14] 
Treatment of COPD 
The treatment of COPD is very diverse. Even though smoking cessation is the most crucial 
factor in prolonging the prognosis, and the only factor that can stop the advancement of the 
disease, many factors are at play when determining the best treatment for a patient. The long-
term treatment can include a better diet, physical exercise, medications, long-term oxygen 
therapy and sometimes prophylactic antibiotics. When talking about pure medical COPD 
treatments different inhalators, SABA and LABA (Short- and Long-Acting Beta-2-Agonists), 
LAMA (Long-Acting Muscarinic Receptor Antagonists) and ICS (Inhaled Corticosteroids), 
are the cornerstones. One of the goals of the long-term treatment is to reduce the number of 
exacerbations, sudden worsening of the symptoms, since these are associated with an 
accelerating progress of the disease and a shorter life-span. Many patients get hospitalized 
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during exacerbations since they are in need of short-term oxygen therapy, more effective 
inhaled medication and intravenous antibiotics. With smoking cessation and proper adherence 
to other recommended treatment progress of the disease can be slowed significantly, or even 
stopped altogether.[10, 14] 
Adherence 
When writing or talking about adherence we often only mean how well the patient follows the 
prescribed regimen and how much they follow the caregiver’s advice. Adherence can be 
looked at from a broader perspective where more dimensions are observed.[6] 
Table 1. Adapted from Sabaté, Eduardo. [6] 
Five Dimensions of Adherence 
Socioeconomic Health care system Condition - Related Therapy - Related Patient - Related 
Limited language 
Patient-provider 
relationship 
Lack of symptoms 
Complexity of the 
medication regimen 
Visual, hearing or 
cognitive impairment 
Low health literacy Long wait times 
Severity of 
symptoms 
Duration of therapy 
Knowledge about 
disease 
Unstable living 
conditions 
Lack of care 
continuity 
Depression Frequent changes 
Perceived risk/ 
susceptibility to 
disease 
Lack of health 
insurance 
Restricted 
formularies 
Psychotic disorders 
Actual perceived 
side effects 
Perceived benefit of 
treatment 
Medication cost    
Motivation and 
confidence 
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Aim 
The aim of the project was to investigate the difference in and impact on both knowledge 
about COPD and adherence to medication between newly admitted patients or recurrent visits 
to the COPD-centre at Sahlgrenska University Hospital. 
Research Questions 
1. Are the patients’ perceived medical adherence unchanged between new and recurrent visits 
to the COPD-centre at Sahlgrenska University Hospital? 
2. Are the patients’ perceived basic knowledge about COPD unchanged between new and 
recurrent visits to the COPD-centre at Sahlgrenska University Hospital? 
3. Is the proportion between actively smoking and non-smoking patients’ unchanged between 
new and recurrent visits as stated to the COPD-centre at Sahlgrenska University Hospital? 
4. Are there any specific demographic differences between groups in relation to questions 1-3, 
or more specifically, if there are any differences between patients’ gender, socioeconomic 
status or age in relation to the questions above?  
Medical Relevance 
Several of the medications used by COPD patients, particularly those acting in longer dosing 
intervals that don’t have an immediate effect, are used less frequently than prescribed even 
though studies have shown clinically relevant benefits in sticking to the regimen.[15] It is 
therefore relevant to find connections between different levels of adherence to treatment 
between groups of patients since such finding could potentially benefit those individuals that 
does not get the best possible potential from their medications.  
In this study the prime difference between the groups are whether they have specialized or 
non-specialized care for treatment of their COPD. If the study would show disparity between 
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the groups, then further studies will most probably be needed to specify which factors are the 
cause of it. 
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Materials and Methods 
To answer the research question about differences in adherence a tool, or method, to measure 
this was needed. Medication Adherence Rating Scale[16] (MARS), a validated tool for 
measuring adherence to medication, was chosen to measure adherence. MARS was chosen 
both because of its broad perspective and for its short length. Due to the nature of the survey 
the patients needed to fill out the form before their appointment with the physician which led 
to a time constraint that limited the number of questions in the form measuring adherence. 
The tool for measuring adherence also needed to be as broad as possible to include all kinds 
of medication. MARS is mostly used for measuring adherence for psychiatric medications, 
therefore slight changes have been made to a few of the questions to better fit the group 
surveyed, more specifically to question number 7 and 9. The questions have also been 
translated into Swedish. 
A second tool measuring the patients’ knowledge was also needed. This part was constructed 
by the author with input from physicians at the clinic. The tool measuring knowledge of 
COPD is a short questionnaire with seven questions about COPD and its treatment in 
Sweden[17]. 
The survey also included questions about gender, age, which neighbourhood or district they 
lived in, smoking habits and how much the disease affected their daily life.  
The questionnaire was handed out to visiting patients for five weeks at the clinic, between the 
16th of October and the 17th of November in 2017, a period that the author had calculated 
would include more than one hundred patients.  
116 patients had an appointment at the clinic during the period. More than 90% of those 
patients answered most of the questions on the questionnaire. The number of included 
12 
 
respondents vary when comparing data. These variations stem from what data the respondent 
have excluded when filling out their form. 
The questionnaire contains as much of the complexity of adherence as could be fitted in to the 
limited time that the patients had when filling out the forms. In Figure 1 you can see what 
parts are included. 
 
Figure 1 - Adapted from Sabaté, Eduardo. [6] 
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Ethics 
The patient could feel uncomfortable answering questions about adherence to medicine since 
it can make them feel accused of not doing what the caregivers has ordered. They could also 
get uncomfortable answering a form about COPD. Both problems are met by having a neutral 
page at the top of the questionnaire that both hides their replies from the staff as well as 
explains that only the one person doing the study will see their individual questionnaires. 
Since the questionnaire was anonymous an approval of conducting the study without having 
an ethical review board’s approval was given by the head of the clinical department. 
There are no issues contrasting the Universal Declaration of Human Rights[18] or the World 
Medical Association’s Declaration of Helsinki[19].  
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Statistical Methods 
SPSS 25 was used to calculate data and to generate graphs and tables.[20] Prior to importing 
the data to SPSS the data was compiled and sorted in Microsoft Excel (2016). 
Knowledge about COPD was calculated with a Mann–Whitney U Test. 
Adherence was calculated by an independent-samples T-test where equal variances weren’t 
assumed. The same was done when looking for a correlation between how much the disease 
affected daily life and their result on the adherence scale. 
Smoking habits between the groups was calculated with a Fisher’s Exact Test.  
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Results 
Demographic Data 
Most patients were above the Swedish age of retirement and none were younger than 45 years 
of age. Almost two thirds of the patients were women. 87% were born in Sweden, which is 
slightly more compared to the population average of 83%.[21] 
Table 2. The age distribution among patients. 
 
Years of Age 
 
45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-85 >85 
Male, n= 41 0% 2% 5% 7% 22% 10% 27% 20% 7% 
Female, n= 70 1% 1% 3% 14% 14% 21% 10% 19% 16% 
Total, n= 111 1% 2% 4% 12% 17% 17% 16% 19% 13% 
 
Table 3. Gender distribution and share of immigrants. 
 
 
 
Gender 
 
Born in Sweden 
 
Male Female Total  Yes  No 
First visit, n= 29 35% 65% 73%  86% 14% 
Recurrent visit, n= 80 45% 55% 27%  90% 10% 
All Visits n= 109 (116) 38% 62% 100%  87% 13% 
 
Table 4. Distribution of background by comparing if parents are immigrants or not. 
 Parents born in Sweden 
  
 Yes One None 
First visit, n= 28 82% 3% 15% 
Recurrent visit, n= 79 86% 4% 11% 
All Visits n= 107 (116) 83% 3% 14% 
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Knowledge of COPD 
103 out of 116 patients did both the questionnaire about COPD and answered the question 
about whether it was a first or recurring visit to the clinic. The maximum value on the 
knowledge questionnaire was 7. The recurring patients had a 0.72-point higher mean, at 3.49, 
than the new patients at 2.77 points. A Mann–Whitney U test showed a significant p-value of 
0.033. 
 
Figure 2 – The patients’ knowledge of COPD 
 
When comparing male and female respondents and including everyone, both new and 
recurring visits, there is a difference of 0.52-points between genders with a maximum test 
score of 7. The difference is not significant. 
 
Table 5. The gender difference in knowledge. 
Gender  N Mean 
Male knowledge 39 3.00 
Female knowledge 65 3.52 
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Smoking Habits 
Out of 116 respondents 109 answered both the question about smoking and about being a new 
or recurring visitor to the clinic. 
Table 6. How many participants that were included when measuring smoking habits. 
 
Included Excluded Total 
n Percent n Percent n Percent 
Patients on smoking 
habits  
109 94% 7 6% 116 100% 
 
When comparing the results on the proportion of smokers between first and recurring visits to 
the clinic we get a 56% reduction, from 34% for first visits down to 15% for the patients that 
have visited the clinic and met a specialist at least once before. Fisher’s Exact Test showed a 
P-value of 0.033 when comparing the groups. 
Table 7. Percentages of active smokers comparing first and recurring visits. 
 Active Smokers 
Recurrent visit, n= 80 15% 
First visit, n= 29 34% 
Total, n= 109 20% 
 
We could follow the smoking habits and the origin of the patients. The sample sizes turned 
out to be too small to draw any conclusions from these statistics. 
Table 8. Shows the distribution of home-address among the participants. 
 First visit Recurrent visit 
 n Smokers % n Smokers % 
Outside Gothenburg 8 2 25% 20 3 15% 
Hisingen 6 4 67% 10 2 20% 
Downtown + Western Goth. 14 4 29% 44 6 14% 
Eastern Gothenburg 1 0 0% 5 1 20% 
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Adherence 
105 out of 116 patients filled out both the form on adherence and answered the question about 
whether it was a first or recurring visit to the clinic. There was a slightly higher mean for the 
patients on MARS, with a maximum of 10, but the data is not normally distributed, and the 
difference is not significant with a p-value of 0.588. 
Table 9. Comparison of the mean self-reported adherence on a scale from 0 to 10 between firt and recurrent visits. 
  N Mean 
Recurrent visit 79 8.49 
First visit 26 8.31 
 
 
Figure 3 - The patients' self-reported adherence to medication. 
The patients’ self-reported adherence compared with how much COPD affects the patients’ 
daily life shows a decrease in how much they are affected with increasing adherence. This 
difference in means is seen both when comparing those that have maximum 10 in adherence 
compared to the rest, and when comparing those with 8 or higher with those lower than 8. 
These correlations are not significant with high p-values. How much the patients were 
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affected was measured on a scale from 0-10 where a lower score equals a lesser impact from 
the disease on their daily life. 
Table 10. The diseases effect on daily life compared to adherence. 
 
 
 
 
Table 11. The diseases effect on daily life compared to adherence. 
 
 
 
 
 Adherence N Mean 
How COPD affects daily 
life  
= 10 32 5.813 
< 10 56 6.196 
 Adherence N Mean 
How COPD affects daily 
life  
>= 8 70 5.957 
< 8 18 6.444 
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Discussion 
Material and Methods 
A confidential survey might have been more optimal but due to time constraints, having the 
survey anonymous was chosen since it might have increased response rates, a factor valued 
when planning this report. Even though anonymity might increase response rates and the 
difference of disclosing sensitive information between an anonymous and a confidential 
survey are unclear[22], a confidential survey would probably have been preferable. One 
clearly negative aspect of having it anonymous is the lack of control; there is no way of 
looking up patients and double-check when things are unclear, and it is impossible to look for 
further data that is not included in the questionnaire. The research gets clearly limited to the 
data you get from the questionnaire, which puts a lot of weight on constructing a survey that 
includes everything essential and making the questions easily understood without room for 
interpretation. 
Knowledge of COPD 
A larger sample might have made a difference, especially when measuring knowledge 
between new and recurring visits since a p-value of 0.033 shows a correlation. 
When comparing genders, results are had that suggests women being treated for COPD have a 
higher health literacy. A study on adults done by the U.S. Department of Education’s National 
Center for Education Statistics, shows a higher general health literacy among women.[23] It is 
interesting to note that this gender difference also shows up in this limited study done in 
Sweden and where the women also have a slightly higher mean age. This suggests that men in 
general need more support if their adherence as a group is to be increased. 
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The importance of educating patients about their disease and its management is crucial in 
getting a higher adherence. Also important is the care-givers skill in assessing the level of 
education needed by individual patients.[24] This paper shows that the patients admitted to 
the COPD-centre at Sahlgrenska University Hospital do increase their knowledge. It is 
unclear if the increase in knowledge is due to better care and education from the staff and 
physicians or if being admitted to a specialist clinic has a direct influence in patients taking 
their disease more seriously and the increase thus being a product of this revelation. 
Smoking habits 
When comparing means on smoking habits they show an effective result in the survey. There 
is a 56% reduction in active smokers between new and recurring visits. This is a huge 
decrease in active smokers and it is significant. The same applies here as in the section above: 
What part of this decrease is due to having been treated by specialist physicians and nurses 
and what part of the decrease is due to other factors? 
Since earlier studies have shown that higher education can lead to higher adherence, in this 
case a lower percentage of smokers, one could assume that an appointment with a specialist 
would be more beneficial for patients from lower socioeconomic areas, in this study Hisingen 
and Eastern Gothenburg.[25, 26] This study failed to show this correlation even though it 
shows a larger reduction in number of smokers from the parts of the city that have a lower 
median income and a lower level of people with degrees from higher education, no 
conclusions can be had from these statistics since the sample sizes are too small. 
Adherence 
The comparison on adherence to therapy was not statistically significant, however it was 
graphically visible. The form analyzing adherence could be improved with more questions 
specifically about COPD medication. Using the MARS as the tool for measuring adherence 
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gave a validated tool, but since two questions were modified and the questions were translated 
into Swedish from English, one could instead have constructed a tool specifically aimed at the 
target population which might have given different results.[16] 
Education is vital and self-management skills are very important in gaining higher 
adherence.[27] Even though this study have shown an increase in patient knowledge and a 
decrease in active smokers, which is a sign of increasing adherence, it fails to show an 
increase in adherence to their medicine regime. 
There are also other methods besides patient education, skillful physicians and care-givers 
that can contribute in increasing adherence to therapy in the chronically ill. Some we might 
start seeing soon as technological advances start to facilitate patients’ self-management.  One 
study from 2017 shows how technology could provide such positive impact on adherence: 
Text messages that reminds patients to take their medications.[8]  
Conclusion and Implications 
If the patient’s knowledge of the disease truly increases by having an appointment at a 
specialist clinic, then that difference in knowledge probably also increases the patient’s 
adherence to medication and counsel given by the physician.[27, 28] A family doctor could 
screen patients knowledge with just small questionaries’ and then either provide additional 
information or refer to a specialist clinic those that lack basic knowledge of COPD. This 
would be an extremely cheap way of increasing adherence among this huge group of patients 
which as a result could lead to less suffering and lower costs for society. 
The caregivers knowledge makes a difference[25], and it is therefore important for family 
doctors to keep up to date with guidelines to give good counsel. If all family practitioners 
were up to date on the basic guidelines of COPD treatment, a specialized clinic focusing on 
COPD is probably still needed for referrals for more advanced stages or those with high 
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comorbidity. The clinic might also be essential in helping other clinics and family practices in 
implementing guidelines and perhaps helping in the job needed to spread information to 
colleagues when new treatments and new guidelines surface. Lastly the clinic is perfect for 
scientific research advancing the knowledge and treatment of COPD.  
Having visited a specialist clinic focused on COPD should not create a drop from 34% to 15% 
in active smokers, as the results of this report show. Family doctors should have knowledge of 
this widespread disease and more knowledge and better adherence to guidelines from 
physicians would most likely reduce the number of smokers and delay the more severe stages 
of the disease. In Sweden, COPD is estimated to cost 14 billion SEK annually[10]. Since the 
more severe stages of the disease are more costly and smoking cessation is the only factor 
stopping the progress of COPD, focusing on the family practices, who are the ones that 
usually treat COPD at the initial stages, would be the most cost-effective way of reducing that 
cost. Even a few percent fewer active smokers among COPD patients would probably save 
billions. 
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Populärvetenskaplig sammanfattning 
Kroniskt obstruktiv lungsjukdom, KOL, ökar i Sverige. KOL, som ofta drabbar rökare, är en 
kronisk sjukdom som leder till sämre lungkapacitet och vid fortsatt rökning krävs ofta syrgas 
och sjukhusvård. Sjukdomen ökar i Sverige och i världen så tror Världshälsoorganisationen, 
WHO, att KOL kommer att bli den tredje vanligaste orsaken till död år 2030. Att förbättra 
KOL-sjukvården skulle kunna leda till minskat lidande och det skulle spara samhället stora 
pengar. 
I september 2015 så togs det på Sahlgrenska sjukhuset ett beslut om att inrätta en klinik som 
fokuserar på sjukdomen KOL. Kliniken är det KOL-centrum som idag finns på Sahlgrenska. 
Enligt beslutet så ska KOL-centrum utvärderas och senast hösten 2018 ska beslut tas om 
kliniken ska göras permanent.  
Den här uppsatsen jämför nya och återkommande patienter till KOL-centrum vad avser deras 
följsamhet till medicinering, deras rökvanor och deras kunskap kring KOL-sjukdomen. 
Patienterna fick fylla i en enkät konstruerad att mäta dessa variabler. Återkommande patienter 
har en bättre kunskap kring sin sjukdom och skillnaden mellan grupperna kan visas statistiskt, 
däremot visar resultaten inte någon skillnad på följsamhet till medicinering även om en 
grafisk skillnad kan ses. Andelen rökare minskar från 34% för nybesöken till 15 % för 
återkommande patienter, vilket ger en reduktion av rökare på 56%. 
Ett besök på KOL-centrum är positivt för patienten. Kunskapen kring sjukdomen ökar, något 
som tidigare studier visat har en positiv verkan på följsamhet till terapin, och andelen rökare 
sjunker markant. Det krävs dock fortsatta studier för att få reda på mer exakt vad i 
behandlingen och mötet på KOL-centrum som leder till dessa positiva resultat. 
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